Follow along with the video below to see how to install our site as a web app on your home screen.
Note: This feature currently requires accessing the site using the built-in Safari browser.
You are using an out of date browser. It may not display this or other websites correctly. You should upgrade or use an alternative browser.
Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page
There was a call and it had nothing to do with restructures. No action here and a national meeting in January. Looks like if something is going to happen, it won't be soon.
Well after listening to the call yesterday, I feel like we have a good 5 years left in respiratory if not more.
I’m just telling you that SP HH won’t be copied here and we can keep things going with SP Respimat but they can’t give up any more insurance coverage.
But Stiolto is kind of flat because of Trelegy